A couple of updates to GILD's previously unnamed Phase 1 HCV compounds GS-5885 NS5A Inhibitor (active, not recruiting.) http://clinicaltrials.gov/ct2/show/NCT01193478?term=GS-5885&rank=1 GS-6620 Nucleotide polymerase inhibitor (recruiting) http://clinicaltrials.gov/ct2/show/NCT01316237?term=GS-6620&rank=1